Filter
1638
Text search:
pharmaceutical
guidelines
Featured
Recommendations
157
New Publications
419
Language
Document type
No document type
811
Studies & Reports
300
Guidelines
296
Strategic & Response Plan
82
Manuals
77
Fact sheets
22
Training Material
21
Situation Updates
11
Resource Platforms
8
Infographics
6
Brochures
3
Online Courses
1
Countries / Regions
Kenya
73
India
67
Ethiopia
65
Global
50
South Africa
49
Nigeria
42
Western and Central Europe
38
Sierra Leone
37
Uganda
34
Namibia
32
Liberia
31
Ghana
29
Zambia
26
Tanzania
26
Rwanda
23
Malawi
23
Africa
21
Nepal
20
Zimbabwe
18
Latin America and the Carribbean
17
Ukraine
16
Eastern Europe
16
Philippines
15
Lesotho
14
Cambodia
11
Bangladesh
11
Eswatini/ Swaziland
11
Indonesia
10
Botswana
10
Myanmar / Burma
9
Germany
8
Brazil
8
Eastern Europe and Central Asia
8
Asia
8
South–East Asia Region
7
Russia
7
Senegal
6
Congo, Democratic Republic of
6
Syria
6
West and Central Africa
6
Cameroon
5
Thailand
5
East and Southern Africa
5
Guinea
4
Burkina Faso
4
South Sudan
4
Mozambique
4
Benin
4
Chile
4
Albania
4
Vietnam
4
Mali
3
Haiti
3
China
3
Papua New Guinea
3
Sudan
3
Middle East and North Africa
3
Laos
3
United Kingdom
3
USA
2
Pakistan
2
Iraq
2
Jordan
2
Western Pacific Region
2
Fiji
2
Tajikistan
2
Kyrgyzstan
2
North America
2
Saudi Arabia
1
Niger
1
Somalia
1
Afghanistan
1
Egypt
1
Malaysia
1
Central African Republic
1
Argentina
1
Peru
1
North Macedonia
1
Serbia
1
Bolivia
1
Angola
1
Venezuela
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Lithuania
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
730
Clinical Guidelines
114
Key Resources
78
Public Health
72
Women & Child Health
41
Pharmacy & Technologies
35
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
181
Pharmacy
167
COVID-19
118
HIV
90
TB
89
Mental Health
71
NTDs
45
NCDs
37
Caregiver
33
Rapid Response
31
Planetary Health
31
Ebola & Marburg
21
Conflict
20
Malaria
19
Global Health Education
14
2.0 Rapid Response
13
Health Financing Toolbox
11
Disability
10
Polio
7
Specific Hazards
7
Natural Hazards
6
Refugee
6
Cholera
4
Zika
4
Social Ethics
1
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The
...
This malaria case management training manual was developed by the Federal Ministry of Health (FMOH) of Ethiopia, in collaboration with several national and international partners. Primarily based on WHO guidelines and training materials, as well as
...
Operational requirements for implementing WHO recommendations in digital systems. 2nd edition.
To ensure that countries can effectively benefit from digital health investments, “digital adaptation kits” (DAKs) are designed to facilitate the accurate reflection of WHO’s clinical, public health
...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef
...
The Health Sector Policy gives general orientations for the sector which are further developed in the various sub-sector policies guiding key health programs and departments. All health sub-sector policies will be updated in line with this new policy. The Health Sector Policy is the basis of nationa
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in
...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant
...
This document sets out the preparedness and response plan of the Nigerian Primary Health Care System for COVID-19 Acute Respiratory Disease. It outlines the planning scenarios, key areas of work and priority activities required for the Primary Health Care Sector to quickly scale up its core capacity
...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca
...
Bioethics - Medical, Ethical and Legal Perspectives
There’s evidence that implementing the four medical ethics principles may be challenging especially in low income country contexts with extreme resource scarcity and limited capacity to facilitate deliberations on the different ethical dilemmas.
...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi
...
In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance, and with standards and
...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib
...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and
...
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G
...
